Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
144
4.290
Why?
Vulvar Neoplasms
6
2024
60
2.650
Why?
Carcinoma, Squamous Cell
9
2024
332
2.110
Why?
Carcinoma in Situ
7
2022
72
1.860
Why?
Uterine Neoplasms
10
2023
60
1.860
Why?
Carcinoma, Endometrioid
6
2021
38
1.540
Why?
Adenocarcinoma
10
2024
405
1.490
Why?
Tumor Suppressor Protein p53
3
2024
221
1.420
Why?
PAX2 Transcription Factor
7
2015
24
1.370
Why?
Ovarian Neoplasms
10
2024
459
1.120
Why?
Uterine Cervical Neoplasms
7
2024
299
1.120
Why?
Endometrial Hyperplasia
4
2019
14
1.080
Why?
Cannabidiol
6
2024
43
1.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
62
1.030
Why?
Stromal Cells
2
2016
79
0.980
Why?
Female
66
2024
28171
0.870
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.860
Why?
Plant Extracts
6
2024
194
0.840
Why?
Myometrium
2
2013
13
0.810
Why?
Endometrium
6
2023
43
0.790
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.740
Why?
Precancerous Conditions
3
2019
85
0.720
Why?
Immunohistochemistry
16
2024
979
0.720
Why?
Cannabis
6
2024
150
0.710
Why?
Aged, 80 and over
20
2024
3392
0.680
Why?
Middle Aged
35
2024
13028
0.660
Why?
Cystadenocarcinoma, Serous
4
2013
73
0.660
Why?
Humans
70
2024
52483
0.650
Why?
Peripheral Nerves
2
2015
44
0.600
Why?
Mutation
9
2024
1347
0.560
Why?
Aged
29
2024
10121
0.550
Why?
Placenta
6
2021
153
0.540
Why?
Cervix Uteri
2
2017
49
0.540
Why?
Epithelial-Mesenchymal Transition
2
2016
57
0.530
Why?
Adult
31
2024
14161
0.520
Why?
Adenosarcoma
1
2016
3
0.520
Why?
Polyps
1
2016
21
0.510
Why?
Uterine Cervical Dysplasia
1
2016
51
0.500
Why?
Lymphatic Metastasis
6
2019
220
0.480
Why?
Neoplasm Staging
9
2024
772
0.480
Why?
Papillomavirus Infections
3
2024
173
0.480
Why?
Fallopian Tubes
2
2012
23
0.480
Why?
Fibroma
1
2015
40
0.480
Why?
Tumor Microenvironment
4
2021
256
0.470
Why?
Prognosis
11
2024
2099
0.430
Why?
Neoplasm Invasiveness
6
2019
278
0.420
Why?
Observer Variation
4
2024
134
0.420
Why?
Pelvic Neoplasms
1
2011
13
0.370
Why?
Uterus
3
2023
88
0.370
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
0.370
Why?
Mice, Inbred C57BL
7
2024
1884
0.340
Why?
Ejaculatory Ducts
1
2010
3
0.340
Why?
Seminal Vesicles
1
2010
13
0.340
Why?
Spectrum Analysis, Raman
2
2021
56
0.330
Why?
Neoplasm Recurrence, Local
4
2015
649
0.330
Why?
Reproducibility of Results
5
2024
1229
0.330
Why?
Prostate
1
2010
116
0.320
Why?
Bromcresol Purple
1
2009
3
0.320
Why?
Electrophoresis, Capillary
1
2009
10
0.310
Why?
Mice
16
2024
5949
0.310
Why?
Serum Albumin
1
2009
58
0.310
Why?
Human papillomavirus 16
2
2021
44
0.300
Why?
Methionine
2
2020
136
0.300
Why?
beta Catenin
2
2021
102
0.290
Why?
Predictive Value of Tests
5
2024
944
0.290
Why?
Disease Progression
4
2020
871
0.290
Why?
Liver
4
2024
1156
0.290
Why?
Diabetes Mellitus
2
2023
316
0.280
Why?
Genital Neoplasms, Female
2
2018
48
0.280
Why?
Papillomavirus Vaccines
2
2021
70
0.280
Why?
Anus Neoplasms
2
2018
25
0.280
Why?
Metaplasia
2
2019
15
0.270
Why?
Cell Proliferation
4
2021
1023
0.270
Why?
Antigens, CD
2
2019
218
0.270
Why?
Diagnosis, Differential
8
2020
1046
0.260
Why?
Prostatic Neoplasms
1
2010
398
0.260
Why?
Colitis
2
2020
51
0.250
Why?
Polyethylene Glycols
2
2017
90
0.250
Why?
Melanoma
2
2020
288
0.250
Why?
Neoplasm Grading
5
2021
126
0.250
Why?
Hypertension
2
2021
565
0.240
Why?
Gold
2
2017
128
0.240
Why?
Animals
17
2024
13505
0.240
Why?
Chi-Square Distribution
2
2016
288
0.240
Why?
Proteomics
3
2017
329
0.230
Why?
Nanoparticles
2
2017
160
0.230
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.230
Why?
Lab-On-A-Chip Devices
1
2024
10
0.230
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.220
Why?
Racemases and Epimerases
2
2015
18
0.220
Why?
Young Adult
7
2024
4329
0.220
Why?
Retrospective Studies
11
2020
6607
0.220
Why?
Carcinoma, Neuroendocrine
1
2024
25
0.220
Why?
Neuroendocrine Tumors
1
2024
23
0.220
Why?
DNA Mutational Analysis
3
2024
180
0.220
Why?
Head and Neck Neoplasms
2
2019
288
0.220
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
44
0.210
Why?
Kidney Neoplasms
2
2018
182
0.210
Why?
Homeodomain Proteins
1
2024
80
0.210
Why?
Chlamydia muridarum
1
2024
40
0.210
Why?
Endometriosis
1
2023
15
0.200
Why?
Lung Neoplasms
2
2019
636
0.200
Why?
Chlamydia Infections
1
2024
76
0.200
Why?
Gynecology
2
2020
52
0.200
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.200
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.200
Why?
CD4-Positive T-Lymphocytes
1
2024
164
0.200
Why?
Hepatocytes
2
2024
190
0.190
Why?
Fallopian Tube Neoplasms
2
2012
15
0.190
Why?
Immunotherapy
2
2021
244
0.190
Why?
Gestational Trophoblastic Disease
2
2012
2
0.190
Why?
CTLA-4 Antigen
1
2021
23
0.190
Why?
Genotype
2
2021
566
0.180
Why?
Estrogens
2
2023
223
0.180
Why?
Fetal Membranes, Premature Rupture
1
2021
23
0.180
Why?
Oncogene Fusion
1
2021
4
0.180
Why?
PTEN Phosphohydrolase
3
2020
55
0.180
Why?
Leiomyosarcoma
1
2021
21
0.180
Why?
Transcription Factors
3
2020
566
0.180
Why?
Diabetes, Gestational
1
2021
53
0.180
Why?
Cancer Vaccines
1
2021
78
0.180
Why?
Carcinosarcoma
2
2017
18
0.170
Why?
Infant, Small for Gestational Age
1
2020
35
0.170
Why?
Neoplasms, Experimental
1
2020
114
0.170
Why?
Carcinoma, Papillary
1
2020
51
0.170
Why?
Carcinoma, Transitional Cell
1
2020
54
0.170
Why?
Pregnancy in Diabetics
1
2020
27
0.170
Why?
Colonic Neoplasms
1
2021
163
0.160
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.160
Why?
Radiotherapy
1
2020
127
0.160
Why?
Carcinoma, Lewis Lung
1
2019
9
0.160
Why?
Dermatology
1
2020
53
0.160
Why?
Placenta Diseases
1
2019
15
0.160
Why?
Pregnancy Complications, Neoplastic
1
2019
24
0.160
Why?
Carcinoma, Renal Cell
2
2018
111
0.160
Why?
Skin Diseases
1
2020
115
0.160
Why?
Premature Birth
1
2021
153
0.160
Why?
Hepatic Veno-Occlusive Disease
1
2019
11
0.160
Why?
Odds Ratio
3
2015
558
0.160
Why?
Melanoma, Experimental
1
2019
40
0.160
Why?
DNA Polymerase II
1
2019
9
0.160
Why?
Hodgkin Disease
1
2019
49
0.160
Why?
DNA Mismatch Repair
1
2019
18
0.160
Why?
T-Lymphocytes
1
2021
340
0.160
Why?
Fetal Diseases
1
2019
61
0.160
Why?
Monocytes
1
2019
130
0.150
Why?
Sarcoma
1
2020
72
0.150
Why?
Inflammation
2
2020
641
0.150
Why?
Pregnancy
7
2021
2680
0.150
Why?
Urinary Bladder Neoplasms
1
2020
165
0.150
Why?
Metformin
1
2020
76
0.150
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
132
0.150
Why?
Nuclear Proteins
1
2020
245
0.150
Why?
Logistic Models
3
2015
925
0.150
Why?
Radiation Tolerance
1
2019
84
0.150
Why?
Disease Models, Animal
6
2020
1478
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.140
Why?
Rhabdomyosarcoma
1
2018
13
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
41
0.140
Why?
DNA Helicases
1
2020
150
0.140
Why?
Intestinal Mucosa
2
2020
224
0.140
Why?
Hypoglycemic Agents
1
2020
211
0.140
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
69
0.140
Why?
Pathology, Molecular
1
2017
28
0.140
Why?
Biopsy
5
2020
605
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
399
0.140
Why?
Osteosarcoma
1
2017
44
0.130
Why?
Pregnancy Complications
1
2021
400
0.130
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Vimentin
1
2016
32
0.130
Why?
Time Factors
3
2021
2968
0.130
Why?
Papillomaviridae
1
2017
105
0.130
Why?
DNA-Binding Proteins
2
2016
422
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
405
0.130
Why?
Acetaminophen
1
2019
279
0.130
Why?
Gene Expression Profiling
2
2019
1105
0.130
Why?
Cadherins
1
2016
62
0.130
Why?
Viral Load
1
2016
82
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Skin Neoplasms
1
2020
505
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.120
Why?
Male
11
2024
26761
0.120
Why?
Classification
1
2015
12
0.120
Why?
Colposcopy
1
2015
17
0.120
Why?
Malate Dehydrogenase
1
2014
8
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.120
Why?
Lipogenesis
1
2014
31
0.120
Why?
Flow Cytometry
1
2017
478
0.120
Why?
Cytosol
1
2014
80
0.110
Why?
World Health Organization
1
2015
59
0.110
Why?
Mice, Inbred BALB C
3
2021
312
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.110
Why?
Neoplasm, Residual
1
2015
173
0.110
Why?
Histones
1
2016
314
0.110
Why?
Adolescent
4
2024
6739
0.110
Why?
Obesity
1
2022
1162
0.110
Why?
Multiple Myeloma
1
2009
3049
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
182
0.110
Why?
Antineoplastic Agents
2
2021
1222
0.110
Why?
Gastrointestinal Tract
1
2014
108
0.110
Why?
Intestines
1
2014
154
0.110
Why?
Oncogenes
1
2013
60
0.100
Why?
Patient Selection
1
2015
259
0.100
Why?
Cell Line, Tumor
4
2020
1470
0.100
Why?
Clusterin
1
2012
8
0.100
Why?
Membrane Proteins
1
2015
335
0.100
Why?
Pancreatic Neoplasms
1
2015
216
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1378
0.100
Why?
Histocytochemistry
1
2012
45
0.100
Why?
Risk Factors
3
2015
3889
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
23
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2279
0.100
Why?
Cytomegalovirus Infections
1
2012
34
0.090
Why?
Treatment Outcome
3
2021
5422
0.090
Why?
Prednisone
1
2012
102
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
182
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.090
Why?
Teratoma
1
2011
24
0.090
Why?
Matrix Metalloproteinases
1
2011
47
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Sensitivity and Specificity
3
2020
891
0.090
Why?
Image Processing, Computer-Assisted
1
2012
253
0.090
Why?
Phenotype
3
2019
789
0.090
Why?
Tissue Array Analysis
3
2015
46
0.080
Why?
Glucocorticoids
1
2012
235
0.080
Why?
Tumor Cells, Cultured
2
2021
460
0.080
Why?
Epigenesis, Genetic
1
2012
406
0.080
Why?
Pilot Projects
2
2023
721
0.080
Why?
Pregnancy Outcome
2
2021
250
0.080
Why?
Infant, Newborn
3
2021
2867
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
151
0.080
Why?
Necrosis
2
2024
176
0.070
Why?
Telemedicine
1
2015
494
0.070
Why?
Cell Differentiation
2
2024
665
0.070
Why?
Hysterectomy
2
2021
90
0.070
Why?
Cell Nucleus
2
2021
187
0.070
Why?
Societies, Medical
2
2019
200
0.070
Why?
Host-Pathogen Interactions
2
2021
144
0.070
Why?
Gene Expression Regulation
3
2023
990
0.070
Why?
Neoplasms
1
2017
1325
0.070
Why?
Consensus
2
2020
181
0.070
Why?
Ventricular Pressure
1
2006
16
0.070
Why?
Isoproterenol
1
2006
55
0.070
Why?
Terminology as Topic
2
2018
70
0.070
Why?
Kaplan-Meier Estimate
2
2018
483
0.070
Why?
Serum Response Factor
1
2006
43
0.060
Why?
Combined Modality Therapy
2
2020
639
0.060
Why?
Kidney
1
2010
707
0.060
Why?
Practice Guidelines as Topic
2
2019
488
0.060
Why?
Neoplasm Metastasis
2
2018
243
0.060
Why?
Cytokines
2
2020
623
0.060
Why?
Cells, Cultured
2
2021
1567
0.060
Why?
Proportional Hazards Models
2
2017
443
0.060
Why?
Chromatography, Liquid
2
2016
240
0.060
Why?
Bilirubin
1
2024
43
0.060
Why?
Species Specificity
1
2024
192
0.060
Why?
Tandem Mass Spectrometry
2
2016
251
0.060
Why?
Heart
1
2006
345
0.050
Why?
Steroids
1
2024
59
0.050
Why?
Th1 Cells
1
2024
55
0.050
Why?
Interleukin-10
1
2024
84
0.050
Why?
Phylogeny
1
2024
231
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
857
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
67
0.050
Why?
Hemorrhage
1
2024
209
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
11
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Parturition
1
2021
50
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
218
0.040
Why?
Quinazolines
1
2021
34
0.040
Why?
Lymphocyte Activation
1
2021
172
0.040
Why?
Vulva
1
2020
18
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
16
0.040
Why?
Metabolic Networks and Pathways
1
2021
93
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
57
0.040
Why?
Alkaline Phosphatase
1
2020
94
0.040
Why?
Risk
1
2021
316
0.040
Why?
Piperazines
1
2021
118
0.040
Why?
Molecular Targeted Therapy
1
2021
133
0.040
Why?
Chemokines
1
2020
79
0.040
Why?
Birth Weight
1
2020
125
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
582
0.040
Why?
Preoperative Period
1
2020
46
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
United States
3
2016
5192
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
36
0.040
Why?
Endothelium
1
2019
37
0.040
Why?
Pyrimidines
1
2021
199
0.040
Why?
Mice, Transgenic
2
2014
552
0.040
Why?
Colon
1
2020
104
0.040
Why?
Chest Pain
1
2019
57
0.040
Why?
Receptors, Progesterone
1
2020
66
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
33
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
61
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Glutamine
1
2020
176
0.040
Why?
Dyspnea
1
2019
78
0.040
Why?
Estrogen Receptor alpha
1
2020
85
0.040
Why?
Liver Function Tests
1
2019
48
0.040
Why?
Fatal Outcome
1
2019
197
0.040
Why?
Mice, Inbred Strains
1
2019
163
0.040
Why?
Drug Synergism
1
2019
150
0.040
Why?
Gestational Age
1
2020
417
0.040
Why?
Imaging, Three-Dimensional
1
2019
154
0.040
Why?
Mice, Nude
1
2019
265
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
220
0.040
Why?
Nephrectomy
1
2018
82
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
133
0.040
Why?
Cell Lineage
1
2018
85
0.040
Why?
Ultrasonography, Prenatal
1
2019
190
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
DNA Copy Number Variations
1
2018
117
0.030
Why?
Skin
1
2020
422
0.030
Why?
Anal Canal
1
2017
27
0.030
Why?
Lymph Nodes
1
2019
258
0.030
Why?
Macrophages
1
2019
379
0.030
Why?
Disease-Free Survival
1
2017
460
0.030
Why?
Dietary Supplements
1
2020
465
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
37
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Child
2
2024
7248
0.030
Why?
Transcriptome
1
2019
370
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
55
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Diet
1
2020
587
0.030
Why?
Signal Transduction
1
2023
1671
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
84
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
123
0.030
Why?
S100 Proteins
1
2015
34
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
64
0.030
Why?
Cell Count
1
2015
149
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Cell Hypoxia
1
2015
83
0.030
Why?
Drug Evaluation, Preclinical
1
2015
146
0.030
Why?
Blood Vessels
1
2015
71
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
52
0.030
Why?
Genetic Predisposition to Disease
1
2018
528
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Immunoenzyme Techniques
1
2014
137
0.030
Why?
Radiotherapy Dosage
1
2015
255
0.030
Why?
Prospective Studies
1
2020
2481
0.030
Why?
Apoptosis
1
2020
1119
0.030
Why?
Proteome
1
2016
171
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
185
0.030
Why?
Likelihood Functions
1
2014
55
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
263
0.030
Why?
Multivariate Analysis
1
2015
591
0.030
Why?
Genes, erbB-1
1
2013
9
0.030
Why?
Vaccination
1
2016
298
0.030
Why?
Lipid Metabolism
1
2014
187
0.030
Why?
Anti-Bacterial Agents
1
2019
807
0.030
Why?
Gene Frequency
1
2013
98
0.030
Why?
Adiposity
1
2014
143
0.030
Why?
SEER Program
1
2013
103
0.030
Why?
Mesentery
1
2012
31
0.030
Why?
Communication
1
2015
257
0.030
Why?
Rural Health Services
1
2015
170
0.020
Why?
Insulin Resistance
1
2014
275
0.020
Why?
Research Design
1
2015
359
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
41
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.020
Why?
Angiopoietin-2
1
2012
15
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Diet, High-Fat
1
2014
236
0.020
Why?
Ovary
1
2012
107
0.020
Why?
Ivermectin
1
2012
11
0.020
Why?
Socioeconomic Factors
1
2015
610
0.020
Why?
Antiparasitic Agents
1
2012
11
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
30
0.020
Why?
Infant
1
2020
3733
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
Algorithms
1
2015
672
0.020
Why?
RNA, Messenger
1
2014
1132
0.020
Why?
Isoenzymes
1
2011
166
0.020
Why?
Interleukin-6
1
2012
278
0.020
Why?
Crohn Disease
1
2012
117
0.020
Why?
Promoter Regions, Genetic
1
2012
467
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Radiography
1
2011
470
0.020
Why?
Risk Assessment
1
2015
1327
0.020
Why?
Cell Line
1
2012
1030
0.020
Why?
Cohort Studies
1
2013
1542
0.020
Why?
Rats
1
2014
3220
0.020
Why?
DNA Methylation
1
2012
592
0.020
Why?
Blotting, Western
1
2006
590
0.020
Why?
Myocardium
1
2006
453
0.010
Why?
Age Factors
1
2006
1132
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description